Suppr超能文献

伊维菌素对布基纳法索复发性盘尾丝虫病流行区淋巴丝虫病流行村盘尾丝虫病的影响。

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.

机构信息

Institut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest, Bobo Dioulasso, Burkina Faso.

Université Ouaga I Pr Joseph ki-Zerbo, Unité de Formation et de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso.

出版信息

PLoS Negl Trop Dis. 2021 Mar 1;15(3):e0009117. doi: 10.1371/journal.pntd.0009117. eCollection 2021 Mar.

Abstract

In Burkina Faso, onchocerciasis was no longer a public health problem when the WHO Onchocerciasis Control Programme in West Africa closed at the end in 2002. However, epidemiological surveillance carried out from November 2010 to February of 2011, showed a recrudescence of infection in the Cascades Region. This finding was made at a time when ivermectin, a drug recommended for the treatment of both onchocerciasis and lymphatic filariasis, had been distributed in this area since 2004 for the elimination of lymphatic filariasis. It was surprising that ivermectin distributed for treating lymphatic filariasis had not prevented the recrudescence of onchocerciasis. Faced with this situation, the aim of our study was to evaluate the effectiveness of ivermectin on the onchocerciasis parasite. The percentage reduction in microfilarial load after treatment with ivermectin was used as a proxy measure for assessing possible resistance. A cohort study was carried out with 130 individuals who had tested positive for microfilariae of Onchocerca volvulus in 2010 using microscopic examination of skin-snip biopsies from five endemic villages. Subjects were followed from July 2011 to June 2012. The microfilarial load of each individual was enumerated by skin-snip biopsy in 2010, prior to the first ivermectin treatment against onchocerciasis under community guidelines. All individuals received two ivermectin treatments six months apart. In 2012, the microfilarial loads were determined again, six months after the second round of ivermectin and the reductions in parasite loads were calculated to measure the impact of the drug. The percentage reduction of the microfilarial loads ranged from 87% to 98% in the villages. In all villages, there was a statistically significant difference between the average microfilarial loads in 2010 and 2012. The level of reduction of microfilarial loads suggests that ivermectin is effective against the recrudescent population of O. volvulus in Cascades Region of Burkina Faso. Further investigations would be necessary to determine the causes of the recrudescence of onchocerciasis. (For French language abstract, see S1 Alternative Language Abstract-Translation of the Abstract into French by the authors.).

摘要

在布基纳法索,2002 年世界卫生组织西非盘尾丝虫病控制规划结束时,盘尾丝虫病已不再是一个公共卫生问题。然而,2010 年 11 月至 2011 年 2 月进行的流行病学监测显示,卡西地区的感染又出现了复发。这一发现是在 2004 年以来该地区为消除淋巴丝虫病而分发伊维菌素(一种用于治疗盘尾丝虫病和淋巴丝虫病的药物)的时候做出的。令人惊讶的是,用于治疗淋巴丝虫病的伊维菌素并没有阻止盘尾丝虫病的复发。面对这种情况,我们的研究目的是评估伊维菌素对盘尾丝虫寄生虫的有效性。用伊维菌素治疗后的微丝蚴负荷减少百分比被用作评估可能的耐药性的替代指标。对 2010 年通过皮肤活检微丝蚴检查呈阳性的 130 名感染旋盘尾丝虫的个体进行了队列研究,这些个体来自五个流行地区的村庄。从 2011 年 7 月至 2012 年 6 月对这些个体进行了随访。在根据社区指南首次进行抗盘尾丝虫病伊维菌素治疗之前,于 2010 年通过皮肤活检对每个个体的微丝蚴负荷进行了计数。所有个体均接受了两次间隔六个月的伊维菌素治疗。2012 年,再次测定微丝蚴负荷,在第二轮伊维菌素治疗后六个月,并计算寄生虫负荷减少率以衡量药物的影响。在各村庄,微丝蚴负荷的减少率范围为 87%至 98%。在所有村庄,2010 年和 2012 年的平均微丝蚴负荷之间均存在统计学显著差异。微丝蚴负荷的降低水平表明,伊维菌素对布基纳法索卡西地区复发的旋盘尾丝虫种群有效。还需要进一步的调查来确定盘尾丝虫病复发的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df61/7920372/9eccb942125d/pntd.0009117.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验